AstraZeneca Recalls BRILINTA Tablets Due to Foreign Zurampic Contamination
AstraZeneca is recalling 40,368 bottles of BRILINTA 90 mg tablets because some bottles contained foreign Zurampic tablets.
- Product
- BRILINTA — BRILINTA (TICAGRELOR)
- Category
- Drug
- Distribution
- Distributed nationwide